Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia

Histology and Histopathology

Volumn 19, Issue 3, 2004, Pages 715-718

  Marchal, Cristóbal ^a   Redondo, M ^a   Padilla, M ^a   Caballero, J ^a   Rodrigo, I ^a   Garcia J ^a   Quian, J ^b   Boswick, D G ^b  

^a HOSPITAL COSTA DEL SOL   (Spain)

^b BOSTWICK LABORATORIES   (United States)

Author keywords

High grade prostatic intraepithelial neoplasia; Immunohistochemistry; Prostate specific membrane antigen; Prostatic carcinoma; PSMA

Indexed keywords

BIOTIN; MONOCLONAL ANTIBODY; PARAFFIN; STREPTAVIDIN;

ADULT; AGED; ANALYTIC METHOD; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SCORING SYSTEM; TISSUE SECTION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 3042742232     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 11Indium-labeled monoclonal antibody CYT-356. J. Urol. 152, 1952-1955.
2. Basso D., Fogar P., Piva M.G., Navaglia F., Mazza S., Prayer-Galetti T., Pagano F. and Plebani M. (2000) Total PSA, free PSA/Total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when? Urology 55, 710-715.
3. Beckett M.L., Cazares L.H., Vlhaou A., Schellhammer P.F. and Wright G.L Jr (1999). Prostate specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer. Clinical Cancer Res. 5, 4034-4040.
4. Bostwick D., Pacelli A., Blute M., Roche P. and Murphy G. (1998). Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma. Cancer 82, 2256-2261.
5. Carter R., Feldman A. and Coyle. F. (1996) Prostate specific membrane antigen is a hydrolase with substrate and pharmacologic characteristic of a neuropeptidase. Proc. Natl. Acad. Sci. USA 93, 749-.
6. Chang S.S., Reuter V.E., Heston W.D., Bander N.H., Grauer S.L. and Gaudin P.B. (1999). Five different anti prostate specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor associated neovasculature. Cancer Res. 59, 3192-3198.
7. Chang S.S., Reuter V.E., Heston W.D., Brian Hutchinson M.S., Lana S.G. and Gaudin P.B. (2000) Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane expression in prostate tissues. Cancer 8, 407-415.
8. Douglas T., Morgan T.O., McLeod D., Moul J.W., Murphy G.P. and Mostofi F.K. (1997). Comparison of serum prostate specific membrane antigen, prostate specific antigen and free prostate specific antigen levels in radical prostatectomy patients. Cancer. 80, 107-114.
9. Epstein J.I., Grignon D.J., Humphrey P.A. McNeal J.E., Sesterhenn I.A., Troncoso P. and Wheeler T.M. (1995). Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am. J. Surg. Pathol. 19, 873-886.
10. Heston W.D. (1997). Characterization and glutamyl preferring carboxipeptidase function of prostate specific membrane antigen: A novel folate hydrolase. Urology 49 (Suppl. 3A), 104-112.
11. Horoszewicz J., Kawinski E. and Murphy G. (1987) Monoclonal antibodies to a new antigenic marker in epithelial cells and serum of prostatic cancer patients. Anticancer Res. 7, 927-936.
12. Israeli R.S., Powell C.T., Corr C.J., Fair W.R. and Heston W.D. (1994). Expression of the prostate specific membrane antigen. Cancer Res. 54, 1807-1811.
13. Kawakami M. and Nakayama J. (1997). Enhanced expression of the prostate specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. Cancer Res. 57, 231-234.
14. Murphy G., Radge H., Kenny G., Barren R., Erikson S., Holmes E. and Douglas T. (1995). Comparison of prostate specific membrane antigen and prostate specific antigen levels in prostate cancer patients. Anticancer Res. 15, 473-479.
15. Okegawa T., Yoshioka J., Morita R., Nutahara K., Tsukada K. and Higashihara E. (1998). Molecular staging of prostate cancer: Comparison of the nested reverse transcriptase polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer. Int. J. Urol. 5, 349-356.
16. Walsh P.C.(1998). The natural history of localized prostate cancer: A guide to therapy. In: Campbell's Urology. Walsh P., Retik A., Vaughan E. and Wein A. (eds.). Philadelphia. (7th edition). Pennsylvania. pp 2539-2546.
17. Zukier L.S. and DeNardo G.L. (1997). Trials and tribulations: oncological antibody imaging comes to the fore. Semin. Nucl. Med. 27, 10-29.